search this site
- ir home
- about us
- investor relations
- Advisers/Registrars
- Annual/Interim Reports
- Online Interim Report
- Online Annual Report
- Investor Presentations
- Calculator & Graph
- Corporate Governance
- Corporate Social Responsibility
- Directors
- Financial Calendar
- Registration
- RNS News
- Share Price Information
- Major Shareholders
- Shareholdings and Electronic Voting
- Director's Share Dealings
- Analyst and Media Coverage
- contact us
Rule 26 Compliance
In accordance with AIM Rule 26, as stipulated by the London Stock Exchange, all AIM-quoted companies are required to disclose certain information on their corporate website.
In compliance with this rule, Sinclair Pharma plc (incorporated in England & Wales registered number 5212852) has provided the following information on this site.
- AIM admission documents
- Annual and interim reports
- Memorandum and Articles of Association
- Business description
- Circulars to shareholders
- Details of nominated advisors/other key advisors
- Directors' biographies
- Directors' responsibilities
- Major shareholders
- Notifications
The information above was updated on 01 October 2008.
For further information regarding Sinclair Pharma's Rule 26 compliance please contact Mariyam Rowat, Communications and Investor Relations, investorrelations@sinclairpharma.com.